180 related articles for article (PubMed ID: 26030244)
1. Neuroendocrine tumors of the luminal gastrointestinal tract.
Grin A; Streutker CJ
Arch Pathol Lab Med; 2015 Jun; 139(6):750-6. PubMed ID: 26030244
[TBL] [Abstract][Full Text] [Related]
2. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
3. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
[TBL] [Abstract][Full Text] [Related]
4. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
Ardill JE; O'Dorisio TM
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.
Stevenson R; Libutti SK; Saif MW
JOP; 2013 Mar; 14(2):155-7. PubMed ID: 23474561
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms.
Gonzalez RS
Surg Pathol Clin; 2020 Sep; 13(3):377-397. PubMed ID: 32773190
[TBL] [Abstract][Full Text] [Related]
7. Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging.
Klimstra DS
Semin Oncol; 2013 Feb; 40(1):23-36. PubMed ID: 23391110
[TBL] [Abstract][Full Text] [Related]
8. Preface: Gastroenteropancreatic system and its tumors: Part 1.
Vinik AI
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):xvii-xviii. PubMed ID: 21095538
[No Abstract] [Full Text] [Related]
9. [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract].
Klöppel G
Pathologe; 2015 May; 36(3):237-45. PubMed ID: 25947223
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
[TBL] [Abstract][Full Text] [Related]
11. Foreword: Gastroenteropancreatic system and its tumors: Part 1.
LeRoith D
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):xiii-xvi. PubMed ID: 21095537
[No Abstract] [Full Text] [Related]
12. Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors.
Kim MJ; Kwon MJ; Kang HS; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Park HC
Biomed Res Int; 2018; 2018():1013640. PubMed ID: 29780816
[TBL] [Abstract][Full Text] [Related]
13. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.
Aggarwal G; Sharma S; Zheng M; Reid MD; Crosby JH; Chamberlain SM; Nayak-Kapoor A; Lee JR
Ann Diagn Pathol; 2012 Dec; 16(6):532-40. PubMed ID: 22917807
[TBL] [Abstract][Full Text] [Related]
14. Sclerosing Tumors of the Gastrointestinal Tract: A Systematic Approach.
Chelliah A; Kalimuthu SN; Chetty R
Int J Surg Pathol; 2019 Aug; 27(5):468-476. PubMed ID: 30955389
[TBL] [Abstract][Full Text] [Related]
15. Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence.
Yamaguchi T; Fujimori T; Tomita S; Ichikawa K; Mitomi H; Ohno K; Shida Y; Kato H
Diagn Pathol; 2013 Apr; 8():65. PubMed ID: 23607525
[TBL] [Abstract][Full Text] [Related]
16. Clinical Presentation and Diagnosis of Neuroendocrine Tumors.
Vinik AI; Chaya C
Hematol Oncol Clin North Am; 2016 Feb; 30(1):21-48. PubMed ID: 26614367
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.
Lindholm DP; Oberg K
Horm Metab Res; 2011 Nov; 43(12):832-7. PubMed ID: 22009449
[TBL] [Abstract][Full Text] [Related]
18. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
[TBL] [Abstract][Full Text] [Related]
19. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O
J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
[TBL] [Abstract][Full Text] [Related]
20. [Pathological implications in the neuroendocrine gastrointestinal system].
Piette C; Polus M; Louis E
Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
